Medical Marijuana

Report: Medical Marijuana & Palliative Care—Prescriber & Patient Perspectives

Download the report or watch the recording presented by Daniel S. Fitzgerald, CEO, and Meghan Oates-Zalesky, CMO, of Apollo Intelligence. 

In 2018, less than a third of US oncologists believed they were informed enough to make recommendations to patients regarding medical marijuana, according to a study conducted by the Journal of Clinical Oncology. Five years later, the Apollo team wanted to understand if prescriber confidence had grown and how patients with chronic pain perceived medical marijuana as a palliative alternative.

  • The adoption of medical marijuana across the U.S. and Europe
  • The considerations affecting patients as they address chronic pain management and the options available to them
  • Physicians’ positions on prescribing medical marijuana for palliative treatment

Get the Report

You may also be interested in:

Medical Science Liaison

MSLs Matter More Than You Think — If They Get It Right 

Medical Science Liaisons have more influence over oncology treatment decisions than most people assume. But that influence is fragile — and highly conditional. A new Konovo survey of 100 US...
Keep Reading
Medical Knowledge

Why OpenEvidence Is Gaining Ground with HCPs

The dominant use cases were not primarily administrative, though administrative support remains part of the picture. Physicians reported turning to OpenEvidence for clinical questions, literature reviews, and complex decision-making, particularly...
Keep Reading

Konovo One Year Anniversary Journey

Konovo’s one-year anniversary page highlights a year of rapid growth, bringing together global teams, technology, and healthcare audiences to create a more connected approach to insights...
Keep Reading